News

Ensysce Biosciences, Inc (NASDAQ:ENSC) stock gained almost 100% with a strong session volume compared to the average volume ...
Headquartered in Pleasanton, California, Boster Biological Technology is making waves in the research community with its ...
A Tennessee family has opened up about their young daughter's devastating battle with a rare disorder that has caused her to ...
Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...
It was a packed house at Yee-Haw Brewing in North Knoxville as hundreds gathered to show their support for the Begbie family and others who have children with Sanfilippo Syndrome.
A powerful editorial published today in Brain Medicine raises alarm about a previously overlooked threat to brain development and public health: the disruption of sterol biosynthesis by common ...
A preclinical study finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity -- two issues that commonly co-occur with ...
An editorial published in Brain Medicine reveals that many widely prescribed medications may disrupt sterol biosynthesis—an essential process for brain development—potentially causing harm similar to ...
Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...
NS-229 is an investigational selective Janus kinase 1 inhibitor designed to prevent tissue damage caused by EGPA by suppressing immune cell activation.